Stock Price Forecast

May 1, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading TransMedics Group, Inc. chart...

About the Company

We do not have any company description for TransMedics Group, Inc. at the moment.

Exchange

Nasdaq

$241M

Total Revenue

167

Employees

$4B

Market Capitalization

-124.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TMDX News

Should You Think About Buying TransMedics Group, Inc. (NASDAQ:TMDX) Now?

3h ago, source:

TransMedics Group, Inc. ( NASDAQ:TMDX ), is not the largest company out there, but it led the NASDAQGM gainers with ...

TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?

6h ago, source: Yahoo Finance

Shares of TransMedics (TMDX) have been strong performers lately ... On a trailing cash flow basis, the stock currently trades at 874.3X versus its peer group's average of 15.7X. This isn't enough to ...

TransMedics Stock Skyrockets, Analysts Call It 'One Of The Best Organic Growth Stories'

1d ago, source:

TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 ...

TransMedics Group Inc.

1d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

TransMedics Group: Founder Led Company With Solid Potential

13d ago, source:

TransMedics has the only FDA-approved multi-organ warm perfusion platform, giving it a competitive advantage in a niche ...

TransMedics: Q1 Earnings Snapshot

2d ago, source:

ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Tuesday reported first-quarter net income of $12.2 million. On a per-share basis, the Andover, Massachusetts-based company ...

TransMedics Group Inc (TMDX) Surpasses Analyst Revenue Forecasts with Stellar Q1 2024 Results

2d ago, source:

TransMedics Group Inc ( NASDAQ:TMDX) released its 8-K filing on April 30, 2024, unveiling its financial results for the first ...

Q1 2024 Transmedics Group Inc Earnings Call

2d ago, source:

Waleed Hassanein; President and CEO; Transmedics Group, Inc. Stephen Gordon; CFO; Transmedics Group, Inc. Laine Morgan; Moderator; Gilmartin Group LLC. Allen Gong; A ...

Transmedics Group

8d ago, source: Forbes

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the ...

TransMedics Group, Inc.

26d ago, source: CNN

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the ...

TransMedics Group Inc TMDX

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...